Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector‐based COVID‐19 vaccine regimens in solid organ transplant recipients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector‐based COVID‐19 vaccine regimens in solid organ transplant recipients
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-08-29
DOI
10.1111/ajt.16818
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. TRANSPLANTATION
- The future of SARS‐CoV‐2 vaccines in transplant recipients: To be determined
- (2021) Emily A. Blumberg et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Reduced humoral response to mRNA SARS‐CoV‐2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus
- (2021) Ayelet Grupper et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunogenicity of SARS‐CoV‐2 BNT162b2 vaccine in solid organ transplant recipients
- (2021) Smaragdi Marinaki et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- BNT162b2 vaccination in heart transplant recipients: clinical experience and antibody response
- (2021) Yael Peled et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
- (2021) Liane Rabinowich et al. JOURNAL OF HEPATOLOGY
- Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
- (2021) Nina H. Schultz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
- (2021) Andreas Greinacher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration
- (2021) Stephanie G. Yi et al. TRANSPLANTATION
- Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)
- (2021) Johannes Korth et al. Viruses-Basel
- Perspectives on COVID-19 vaccination among kidney and pancreas transplant recipients living in New York City
- (2021) Demetra Tsapepas et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Efficiency of a boost with a third dose of anti‐SARS‐CoV‐2 messenger RNA‐based vaccines in solid organ transplant recipients
- (2021) Arnaud Del Bello et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cellular and humoral response after MRNA‐1273 SARS‐CoV‐2 vaccine in kidney transplant recipients
- (2021) David Cucchiari et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
- (2021) Ilies Benotmane et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
- (2021) Ilies Benotmane et al. KIDNEY INTERNATIONAL
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept
- (2021) Michael T. Ou et al. TRANSPLANTATION
- Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients
- (2021) Rommel Ravanan et al. TRANSPLANTATION
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
- (2020) David Schub et al. JCI Insight
- Impact of COVID‐19 in solid organ transplant recipients
- (2020) Lara Danziger‐Isakov et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More